IBioBA and the Hospital Italiano, side by side to fight renal carcinoma
Researchers and physicians working at the two centers discovered a mechanism that intervenes in the process of tumor expansion. In the future, it could be used as an early marker of malignancy and improve response times. Von Hippel-Lindau syndrome is a rare genetic disorder that affects 1 in 36,000 people. The mutation of a gene,…
